A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
If you're a fan of "A Court of Thorns and Roses," you'll love the new cookbook by Portland-area writer Chelsea Cole that is ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
Jon Batiste shared a positive update on his wife Suleika Jaouad's health following her September 2024 announcement that she'd ...
Esha Nadeswaran, from Ilford, London, was diagnosed with acute myeloid leukaemia - a rare and aggressive cancer affecting the bone marrow and blood, after her parents noticed unusual symptoms ...
21h
India Today on MSNIndia's first homegrown Car-T cell therapy shows 73% success rate against cancerThe Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.
The parents of brave Esha Nadeswaran are urging people to keep an eye out for symptoms of acute myeloid leukaemia ...
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...
EsoBiotec’s platform has the potential to eliminate the complex and time-consuming process for manufacturing, helping to make CAR-T cell therapies more accessible.
On March 12, 2025, China's Center for Drug Evaluation (CDE) approved Tasly's Investigational New Drug (IND) application for NR-20201, an allogeneic adipose-derived mesenchymal stromal cell, sparking ...
I am not a paleontologist. However, I am a formally trained researcher, and an area of keen interest for me is biblical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results